Hindustantimes wants to start sending you push notifications. Click allow to subscribe

Covaxin likely to be approved for children by Sept: Dr Randeep Guleria

AIIMS director Dr Randeep Guleria said data Covaxin’s phase 2 and 3 trials for children would be made available by September, adding that the vaccine itself could be approved in the same month.
Covaxin likely to be approved for children by September, says Dr Randeep Guleria (PTI Image/Used for representative purpose only)
Updated on Jun 23, 2021 10:27 AM IST
Byhindustantimes.com | Written by Karan Manral | Edited by Amit Chaturvedi, New Delhi

All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria has said that Bharat Biotech International Limited's anti-Covid-19 shot, Covaxin, is likely to be approved for children by September.

Also Read | Bharat Biotech likely to attend pre-submission meeting with WHO for Covaxin emergency use listing

"After the completion of the second and third phase of trials of Covaxin for children, the trial data would be made available by September and the vaccine itself is likely to be approved in the same month," Dr Guleria told India Today. He added that the Pfizer-BioNTech shot, if approved in India, could be another alternative for children to be vaccinated with.

Also Read | Pfizer CEO says Covid-19 vaccine in final stages of approval in India

As several experts have projected that a potential third Covid-19 wave will be particularly hard-hitting on children, Covaxin is being trialled in children, aged between 2 and 17, at AIIMS Delhi and Patna. On May 12, the Drugs Controller General of India (DCGI) granted Bharat Biotech permission to conduct phase 2 and 3 trials for children.


Also Read | AIIMS Delhi to begin recruiting children between 6 and 12 years for Covaxin trial

Dr Guleria, however, disagreed that children will be particularly impacted by a potential third wave, saying there is "no reason to believe this theory." This is in line with a recent AIIMS-World Health Organization (WHO) report which stated that the third wave "may not hit children disproportionately."

Also Read | Third Covid wave may not hit kids disproportionately: WHO-AIIMS sero survey

The senior doctor also called upon policy makers to consider reopening schools, though he also said it should be ensured that educational institutes do not become "super spreaders." Dr Guleria suggested that this could be achieved by opening schools on alternate days in containment zones, and making children follow Covid-19 appropriate behaviour.

This site uses cookies

This site and its partners use technology such as cookies to personalize content and ads and analyse traffic. By using this site you agree to its privacy policy. You can change your mind and revisit your choices at anytime in future.